Glucagon-like peptide-1 (GLP-1) receptor agonists represent one of the most actively studied classes of peptides in metabolic research. This guide provides an overview of three key compounds — Semaglutide, Tirzepatide, and Retatrutide — for researchers working with incretin-based peptides in laboratory settings.
All information in this guide is intended for laboratory and research purposes only. Not for human consumption or medical advice.
What Are GLP-1 Receptor Agonists?
GLP-1 receptor agonists are synthetic peptides that mimic the incretin hormone glucagon-like peptide-1. In research contexts, these compounds are studied for their interaction with the GLP-1 receptor (GLP-1R), a class B G-protein-coupled receptor expressed in pancreatic beta cells, the central nervous system, and various peripheral tissues.
Key areas of research interest include:
- Receptor binding affinity and selectivity assays
- Intracellular signaling cascade activation (cAMP, PKA pathways)
- Metabolic pathway modulation in cell culture models
- Structure-activity relationship (SAR) studies
- Pharmacokinetic profiling and half-life extension mechanisms
Semaglutide Research Profile
| Mechanism | Selective GLP-1 receptor agonist |
| Molecular Weight | ~4,113.58 Da |
| CAS Number | 910463-68-2 |
| Molecular Formula | C187H291N45O59 |
| Sequence Length | 31 amino acids (modified GLP-1 analog) |
Research Applications
Semaglutide is widely used in metabolic research due to its long-acting GLP-1 receptor agonism. Its C-18 fatty diacid modification enables albumin binding, extending its functional half-life in experimental models.
- GLP-1R binding affinity assays and competitive displacement studies
- In vitro insulin secretion studies using pancreatic beta cell lines (INS-1, MIN6)
- cAMP accumulation assays for receptor activation profiling
- Appetite regulation pathway studies in animal models
Published Research Concentrations
In published literature, researchers have utilized semaglutide at varying concentrations depending on the experimental system:
- In vitro receptor binding assays: 0.1 nM – 1 µM concentration ranges
- Cell-based functional assays: 1 nM – 100 nM typical working concentrations
- In vivo studies in published literature have reported weight-adjusted concentrations ranging from 1–60 nmol/kg in animal models
Storage Recommendations
- Lyophilized powder: Store at -20°C. Stable for 24+ months when kept desiccated.
- Reconstituted solution: Store at 2–8°C. Use within 30 days. Avoid repeated freeze-thaw cycles.
- Reconstitute with bacteriostatic water or sterile PBS for research applications.
Tirzepatide Research Profile
| Mechanism | Dual GIP/GLP-1 receptor agonist |
| Molecular Weight | ~4,813.45 Da |
| CAS Number | 2023788-19-2 |
| Molecular Formula | C225H348N48O68 |
| Sequence Length | 39 amino acids |
Research Applications
Tirzepatide is a dual-agonist peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. This dual mechanism makes it a particularly interesting compound for studying incretin synergy.
- Dual receptor selectivity and cross-reactivity profiling
- Comparative studies of GIP vs. GLP-1 receptor signaling pathways
- Synergistic effects of dual incretin activation on glucose metabolism
- Lipid metabolism and adipose tissue studies
Published Research Concentrations
In published research, tirzepatide has been studied across a range of experimental concentrations:
- Receptor binding assays: 0.01 nM – 10 µM ranges for dose-response curves
- Cell-based GIP/GLP-1 activation assays: 0.1 nM – 100 nM working concentrations
- In vivo animal model studies in the literature report weight-adjusted ranges of 1–100 nmol/kg
Storage Recommendations
- Lyophilized powder: Store at -20°C. Stable for 24+ months desiccated.
- Reconstituted solution: Store at 2–8°C. Use within 28 days.
- Protect from light. Avoid repeated freeze-thaw cycles.
Retatrutide Research Profile
| Mechanism | Triple-agonist: GIP / GLP-1 / Glucagon receptor agonist |
| Molecular Weight | ~4,625.25 Da |
| CAS Number | 2381089-83-2 |
| Molecular Formula | C219H338N48O63 |
| Sequence Length | 39 amino acids |
Research Applications
Retatrutide is a novel triple-agonist peptide that simultaneously activates GIP, GLP-1, and glucagon receptors. The addition of glucagon receptor agonism differentiates it from dual-agonist compounds and opens unique research avenues.
- Triple receptor activation profiling and selectivity studies
- Glucagon receptor contribution to metabolic effects (energy expenditure, hepatic glucose output)
- Comparative efficacy studies vs. mono- and dual-agonists
- Body composition and lipid metabolism research in animal models
Published Research Concentrations
As a newer research compound, published concentration data for retatrutide is still emerging:
- In vitro receptor activation assays: 0.01 nM – 1 µM dose-response ranges
- Functional cell-based assays: 1 nM – 100 nM concentrations reported
- In vivo studies in published literature have explored weight-adjusted ranges of 0.5–100 nmol/kg in animal models
Storage Recommendations
- Lyophilized powder: Store at -20°C. Protect from moisture.
- Reconstituted solution: Store at 2–8°C. Use within 21 days.
- Aliquot reconstituted solutions to minimize freeze-thaw degradation.
Comparison Table
| Property | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Receptor Targets | GLP-1 | GIP + GLP-1 | GIP + GLP-1 + Glucagon |
| Molecular Weight | ~4,113 Da | ~4,813 Da | ~4,625 Da |
| Sequence Length | 31 aa | 39 aa | 39 aa |
| CAS Number | 910463-68-2 | 2023788-19-2 | 2381089-83-2 |
| Lyophilized Storage | -20°C | -20°C | -20°C |
| Reconstituted Stability | ~30 days at 2–8°C | ~28 days at 2–8°C | ~21 days at 2–8°C |
Reconstitution & Preparation
For detailed guidance on reconstituting lyophilized peptides, including concentration calculations and syringe volume references, visit our Peptide Reconstitution Calculator.
General reconstitution principles for GLP-1 peptides:
- Use bacteriostatic water (0.9% benzyl alcohol) for multi-use reconstitution
- Add solvent slowly along the vial wall — do not agitate or vortex
- Gently swirl until fully dissolved (typically 1–3 minutes)
- Record reconstitution date and concentration on the vial label
Order Research-Grade GLP-1 Peptides
CertaPeptides supplies high-purity (≥98%) GLP-1 research peptides with a Certificate of Analysis included with every order. All products are intended for laboratory and research purposes only.
- Browse the full catalog
- Learn about our 5-point quality testing protocol
- Contact our research support team
Free shipping on orders over €150 across the EU.
Disclaimer: This guide is provided for educational and research reference purposes only. CertaPeptides products are sold exclusively for laboratory and research use. Not for human consumption. Nothing in this guide constitutes medical advice, therapeutic recommendation, or encouragement for non-research use. Always consult published peer-reviewed literature for experimental protocol design.